Skip to content
Request the Test
Empowering Families Through Science-Backed Insights

Earlier Insights Into Autism Risk

Uncertainty around your child's development can feel overwhelming. NeuroQure offers biology-based, science-backed autism risk insights that help families and clinicians better understand development earlier—so you’re not navigating the waiting alone.

  • Earlier Information – Biology-based information available in infancy
  • Insight, Not Labels – ASD Insight™ is not a diagnosis and does not define outcomes
  • Actionable Insights – Helps families and clinicians decide when closer monitoring or follow-up may be helpful
Request the Test
Screenshot 2026-01-08 at 4.34.02 PM
mother-and-daughters-2025-01-29-09-31-06-utc-1

Why are early insights into autism risk important?

Most autism evaluations rely on observed behaviors that often can’t be reliably assessed until 18–24 months or later. By identifying risk factors early, families can improve access to resources and interventions that support development and learning. ASD Insight™ makes it easier to take that important first step toward informed planning and care. 

Request the Test

Early insights can help families

Intervene earlier

Early intervention may include developmental monitoring, speech therapy, occupational therapy and behavioral interventions.

Feel more informed

ASD Insight™ helps set parents and families on a more informed path forward by providing objective, intrinsic biological information that can support earlier awareness, monitoring, and decision-making.

Collaborate with clinicians

ASD Insight™ precedes and complements other screenings by contributing a biological signal that can help guide earlier monitoring strategies and follow-ups.

Autism by the numbers

1 in 31
children in the US are affected by autism
4.9
is the current average age of diagnosis
17+
average IQ improvements when intervention begins before age 2
What does testing for autism risk show?
In a landmark study published in 2017, scientists discovered that calcium signaling in skin cells had a pattern specific to individuals with ASD. The study defined positive and negative patients based on results from the gold standard test, research-grade Autism Diagnostic Observation Schedule (ADOS). Signals in positive individuals were significantly and reproducibly different than those in patients scored as neurotypical by ADOS. This notable difference is the scientific basis for the NeuroQure test available today. 
What is the NeuroQure ASD Insight™ test?

ASD Insight™ is a test that can detect risk for autism in approximately 75% of people who will eventually be diagnosed with autism spectrum disorder (ASD). This test is performed on cultured fibroblasts obtained from a skin sample. Scientific research has demonstrated that calcium signaling in fibroblasts reflect the signaling patterns in brain neurons, and specific patterns of calcium signaling in fibroblasts have been reliably associated with autism spectrum disorder (ASD) diagnosed by the Autism Diagnostic Observation Schedule (ADOS). 

My child is not at risk for ASD, nor do I have a family history. Is the ASD Insight™ detection test really for us?
ASD is common and impacts 1 in 31 children. Knowing more about your risk can empower you and your family in the early diagnosis and intervention of a child with ASD. While one test cannot exclude a risk of ASD, an ASD Insight™ result that does not detect the autism risk signal lowers the likelihood of a child subsequently being diagnosed with ASD. For individuals without a known family history of ASD, ASD Insight can still be ordered to evaluate whether they have the autism risk signal.
What does a skin biopsy look like?
A 3mm punch biopsy of the skin is a quick procedure that uses a simple device with an opening smaller than the size of a pencil eraser that removes a small circle of skin. Healthcare providers can perform a skin biopsy in minutes, and if requested, a local anesthesic may be applied to minimize any discomfort. The biopsy area is so small that it easily heals without a suture. 
What happens if my child receives a "risk detected" ASD Insight™ test result?
A follow-up evaluation is recommended and encouraged if the autism risk signaling pattern is detected on your child's ASD Insight™ test. Regardless of the result, children should still undergo routine monitoring for autism. Early intervention is key, so it's important to act quickly. A diagnosis opens doors to important resources and services, such as specialized therapies and educational support, to help your child develop and thrive. 
How can I order the ASD Insight™ risk detection test?
Your own healthcare provider can order the test, or you can use our website to connect with a qualified provider through our partner, SteadyMD, who will review your information and order the test if it’s appropriate. To request a test through our website, please visit www.neuroqure.com/order.
Does insurance cover ASD Insight™?
ASD Insight™ test is not expected to be covered by insurance when it is first available. ASD Insight™ will be available initially on a self-pay basis. Patients can sign up to receive updates on the status of insurance reimbursement at https://www.neuroqure.com/contact-us. 
Screenshot 2026-01-08 at 4.42.00 PM

You don't have to wait

Request the Test